CA 15.3 / SERUM

image not found

NABL Cap Accredited 
The CA 15.3 test measures a tumor-associated antigen in serum and is primarily used in monitoring breast cancer treatment and detecting disease recurrence. While not used for screening, it offers valuable insight when interpreted alongside imaging and clinical assessment. Metropolis Healthcare uses sensitive immunoassay techniques to ensure precise and consistent measurement of CA 15.3 levels. This test supports clinicians in tracking disease progression and evaluating therapeutic response.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 1,575.00

Sample Type: SERUM

Fasting Not Required


Notes: C0006

Frequently Asked Questions (FAQ's):

What does this test include?
This test measures CA 15.3 antigen levels in serum, performed with accuracy by Metropolis Healthcare.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced immunoassay technology to quantify CA 15.3 reliably.

Who should take this test?
Patients diagnosed with breast cancer or those undergoing follow-up can benefit from this test at Metropolis Healthcare.

Can CA 15.3 detect cancer on its own?
No, Metropolis Healthcare interprets this marker only in conjunction with imaging and clinical findings.

Do I need to fast before this test?
No fasting is required; Metropolis Healthcare only needs a serum sample.

What do rising levels indicate?
Increasing levels at Metropolis Healthcare may suggest disease progression or recurrence.

Are elevated levels always due to cancer?
Metropolis Healthcare notes that some benign conditions can also influence CA 15.3 levels.

How long does it take to get results?
Metropolis Healthcare delivers timely results to support effective patient monitoring and care.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab